Sangui Obtains First Product Authorization Chitoskin Wound Pad Gets CE Mark Authorizing Sales in European Union.WITTEN, Germany -- SanguiBioTech GmbH has been awarded the CE mark for its "Chitoskin" wound pads. The CE mark authorizes the company to distribute and sell this medical product in the member countries of the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community with immediate effect. In the German speaking countries the product will be distributed by Karl Beese GmbH, a leading vendor and distributor of hospital supplies. At the same time Sangui GmbH successfully passed the ISO (1) See ISO speed. (2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI. 9001:2000 (General Quality Management System) and ISO 13485:2003 (Quality Management System Medical Products) audits, and obtained the respective certifications. "Chitoskin" is the first medical product for which Sangui has obtained an authorization. The "Chitoskin" trademark was already granted to the company for the European countries effective November 1, 2004. Wound pads are being used to support delicate wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by processes. Sangui's Chitoskin product is expected to show significant advantages over existing technologies, as the natural polymer chitosan of which it is composed has outstanding properties playing an important role in wound healing. Due to its specific molecular structure, chitosan demonstrates in all phases of wound healing not only the desired physical characteristics but also most favorable biological effects, caused by the chemical similarity with the natural matrix. Unique selling points selling point n. An aspect of a product or service that is stressed in advertising or marketing. Noun 1. selling point - a characteristic of something that is up for sale that makes it attractive to potential customers of "Chitoskin" wound pads include: Accelerated wound healing as compared to traditional wound pads, low cost and easy production, favorable effects in all phases of wound healing; reduced number of pad changes and, therefore, less expensive and more comfortable treatment. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. market research by Frost&Sullivan the total European market for wound management currently has a volume of EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 4,100 million, of which the available market of advanced wound pad technologies has a share of EUR 550 million. UK medical products corporation Smith & Nephew estimates that the global available market for treatment of chronical wounds will grow to GBP GBP In currencies, this is the abbreviation for the British Pound. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 7,100 million by the year 2020. SanguiBioTech GmbH is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Sangui BioTech International, Inc. (www.pinksheets.com:SGBI). For more information please contact: Some of the statements contained in this news release discuss future expectations, contain projections of results of operation or financial condition or state other "forward-looking" information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions. Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and variations of such words and similar expressions are intended to identify such forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion